Tomocube, Inc. is attending the IMC21 conference on second generation holotomography and live labelfree 3D quantitative imaging applications.
Published
Signal category
Presence & Recognition
Quote
“Let’s talk about second generation #holotomography and explore interesting #live #labelfree #3D #quantitative imaging applications.”
— Daniel Ghete|Tomocube, Inc. team
Company
Tomocube, Inc.
See your samples like never before with Tomocube’s revolutionary label-free, live cell Holotomography
- Industry
- Biotechnology Research
- Location
- Daejeon, KR
- Company size
- 64 employees
See your samples like never before with Tomocube’s revolutionary label-free, live cell Holotomography. Established in 2015, Tomocube is dedicated to delivering products that enhance biological and medical research via novel optical solutions that can assist scientists and clinicians in understanding, diagnosing, and treating human diseases. Holotomography (HT) technology provides label-free 4D quantitative imaging for analyzing cells and tissues. The details of live cell dynamics, subcellular organelles, and tissue structures can be seen without preparation including fixation, transfection, or staining. Image data acquisition is supported by AI-driven data analysis software for phenotypic analysis using cellular and sub-cellular segmentation. For more on our products and research, e-mail us on info@tomocube.com or visit us at www.tomocube.com
Founded 2015